<Disease><Name>[ARTEFACTS AND PITFALLS ]: PHARMACEUTICAL PRODUCTS, INTERFERENCE IN AMINOACID AND ORGANIC ACID ANALYSIS: ACETAMINOPHEN</Name><Synonym>PITFALLS IN AMINOACID AND ORGANIC ACID ANALYSIS</Synonym><OMIM><Number /><URL /></OMIM><Orphanet><Number /><URL /></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene /><ICD /><Summary>Pitfalls in aminoacid and organic acid analysis and skin;biopsy due to metabolites of dietary origin, medications and additives:;PARACETAMOL (ACETAMINOPHEN), reversible inhibition of glutathione synthetase, inhibition of glutathione synthetase (GS) by;N-acetyl-p-benzoquinone imine (NAPQI)?</Summary><Symptoms><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>72</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>42.00</min><max>115.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>560</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>563</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1168</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>77.00</min><max>133.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1284</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>blood</specimen><value>increased</value><min>14.00</min><max>62.54</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1285</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>serum</specimen><value>increased</value><min>23.80</min><max>106.32</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1977</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>10.20</min><max>32.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>394</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>plasma</specimen><value>increased</value><min>13.00</min><max>161.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>559</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite></Metabolites><Literatures><literature><id>3856</id><title>Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case report</title><author>Lanoy C,</author><journal>J Med Case Rep</journal><year>2016</year><book /><volume>10</volume><number>1</number><pages>184</pages><co_aut>Bouckaert Y</co_aut></literature><literature><id>3857</id><title>The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mech</title><author>Walker V,</author><journal>Xenobiotica</journal><year>2016</year><book /><volume>47</volume><number>2</number><pages>164-175</pages><co_aut>et al.</co_aut></literature><literature><id>3858</id><title>[5-0xoproline (pyroglutamic acid) acidosis and acetaminophen- a differential diagnosis in high anion gap metabolic acidosis]</title><author>Weiler S,</author><journal>Ther Umsch</journal><year>2015</year><book /><volume>72</volume><number>11</number><pages>737-741</pages><co_aut>Bellmann R, Kullak-Ublick GA</co_aut></literature><literature><id>3859</id><title>Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report</title><author>Abkur TM,</author><journal>J Med Case Rep</journal><year>2014</year><book /><volume>8</volume><number>0</number><pages>409</pages><co_aut>et al.</co_aut></literature><literature><id>3287</id><title>What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamo</title><author>Liss DB,</author><journal>Clin Toxicol (Phila)</journal><year>2013</year><book /><volume>51</volume><number>9</number><pages>817-827</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>